arrow
BackJournal Details
P

Psoriasis-Targets and Therapy

IF5.7
Papers121
Citations559
Journal Papers 121
Publication Date
Impact of Psoriasis on Patient Well-Being Across Life Stages: A Cross-Sectional Survey (Inpsight Working Group)
delete2026-07-29
delete0
deleteOAAI
deleteEsteban Daudén; Pablo De la Cueva; Isabel Belinchón; Fernando Gallardo; Pablo Coto; Ricardo Ruiz-Villaverde; José Luís Poveda; Esther Ramirez; Elena Colominas; Sandra Ros; Santiago Alfonso; Dámaris López-Pérez; Marta Comellas
deleteShare
deleteSave
Sugary Drinks and High-Fat Foods are Associated with Poor Treatment Response in Psoriasis: A Prospective Study in Shanghai
delete2026-07-14
delete0
deleteOAAI
deleteJiankun Song; Yue Luo; Rui Zhang; Xiangjin Gao; Fanlingzi Shen; Ruiqi Cai; Jinrong Lu; Haotian Xu; Xin Ma; Bin Li; Wencheng Jiang; Ruiping Wang
deleteShare
deleteSave
Paraneoplastic Papuloerythroderma of Ofuji Masquerading as Worsening Psoriasis
delete2026-05-22
delete0
deleteOAAI
deleteMegan Hauptman; Nikhil Mehta; Frank Wang; Lori Lowe; Mio Nakamura
deleteShare
deleteSave
Core Differentially Expressed Genes in Psoriasis Lesions: An Integrated Analysis of Four GEO Datasets
delete2026-01-01
delete0
deleteOAAI
deleteEnnouri, Mariem; Gormez, Zeliha; Bahloul, Emna; Becha, Merouane Khalil; Elleuch, Noura Bougacha; Inal-Gultekin, Guldal
deleteShare
deleteSave
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study
delete2025-09-16
delete0
deleteOAAI
deleteEdoardo Mortato; Marina Talamonti; Lorenzo Marcelli; Matteo Megna; Annunziata Raimondo; Giacomo Caldarola; Nicoletta Bernardini; Anna Balato; Anna Campanati; Maria Esposito; Claudio Bonifati; Viviana Lora; Luca Potestio; Serena Lembo; Francesco Loconsole; Eleonora De Luca; Nevena Skroza; Dario Buononato; Tommaso Bianchelli; Maria Concetta Fargnoli; Nello Tommasino; Caterina Foti; Clara De Simone; Luca Bianchi; Marco Galluzzo
deleteShare
deleteSave
Epidemiology of Hypertension in Psoriasis: An Analysis of Trends from 2006 to 2023
delete2025-08-27
delete0
PREAI
deleteMiao Zhang; Jia-Le Chen; Si-Wei Fan; Xiao-Ying Sun; Ya-Qiong Zhou; Ying Luo; Jiao Wang; Chun-Xiao Wang; Nai-Xuan Lin; Liu Liu; Xin Li
deleteShare
deleteSave
Biosimilars for the Treatment of Moderate to Severe Chronic Plaque Psoriasis
delete2025-08-18
delete0
deleteOAAI
deletePaolo Gisondi, Francesco Bellinato, Tea Curic, Giampiero Girolomoni
deleteShare
deleteSave
Beyond Skin Clearance: Personalized Strategies for DLQI Improvement in Psoriasis -Insights From a Shanghai Prospective Cohort
delete2025-08-13
delete0
deleteOAAI
deleteXin Ma; Quanruo Xu; Le Kuai; Fanlingzi Shen; Zhen Duan; Xiangjin Gao; Rui Zhang; Ruiping Wang
deleteShare
deleteSave
Utilization and Costs of Laboratory Monitoring in Biological and Non-Biological Psoriasis Treatment – Large-Scale Claims Data Analysis
delete2025-08-05
delete0
deleteOAAI
deleteJan Nicolai Wagner; Kristina Hagenström; Katharina Sophia Müller; Brigitte Stephan; Matthias Augustin; Ralph von Kiedrowski
deleteShare
deleteSave
Bimekizumab: The First FDA-Approved Dual IL-17A/IL-17F Inhibitor for Plaque Psoriasis – A Comprehensive Literature Review
delete2025-08-05
delete0
deleteOAAI
deleteSukainah Ahmed Al Alshaikh, Zahra Mohammad Almarhoon, Hisham Momattin, Mahdi Aleid, Zahra H Almousa, Ali Kamal Alqaisum, Fatimah Ismail Mobarki, Sarah Aon Almakki, Hamzah Alturfi, Kouther Jamil Almajed
deleteShare
deleteSave
Effectiveness and Safety of Tildrakizumab in Elderly and Frail Elderly Psoriatic Patients Up to 2 years
delete2025-08-04
delete0
deleteOAAI
deleteLuca Mastorino; Paolo Dapavo; Martina Burlando; Paolo Gisondi; Carlo Alberto Maronese; Angelo Ruggiero; Marco Galluzzo; Maria Carla Pisani; Lidia Sacchelli; Giacomo Caldarola; Gianluca Avallone; Angelo Valerio Marzano; Matteo Megna; Elena Campione; Francesco Loconsole; Federico Bardazzi; Clara De Simone; Pietro Quaglino; Simone Ribero; Collaborators from the working group for Frail-PsO Group: Angela Fico and Fabio Artosi. Both are affiliated with Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy and Dermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy. On behalf of Frail-PsO Group
deleteShare
deleteSave